Omada Health, Inc. (NASDAQ:OMDA) Receives $23.57 Consensus Target Price from Analysts

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) has been given an average recommendation of "Buy" by the seven research firms that are covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $23.57.

Several research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Omada Health to a "hold" rating in a research report on Monday, June 16th. Needham & Company LLC assumed coverage on shares of Omada Health in a research report on Tuesday. They set a "buy" rating and a $23.00 target price on the stock. JPMorgan Chase & Co. started coverage on shares of Omada Health in a report on Tuesday. They issued an "overweight" rating and a $19.00 price target for the company. Morgan Stanley began coverage on shares of Omada Health in a research report on Tuesday. They issued an "overweight" rating and a $25.00 price objective for the company. Finally, Evercore ISI began coverage on Omada Health in a research report on Tuesday. They issued an "outperform" rating and a $21.00 price objective on the stock.

Omada Health Stock Up 2.9%

OMDA stock traded up $0.53 during trading on Tuesday, hitting $18.63. The company had a trading volume of 343,945 shares, compared to its average volume of 1,134,497. Omada Health has a fifty-two week low of $14.14 and a fifty-two week high of $28.40.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.